Dextromethorphan and guaifenesin use ought to be monitored diligently in individuals with "weak metabolizer" CYP2D6 enzyme amounts and people who're sedated. This mix medication includes a large median poisonous dose (TD50) to median helpful dose (ED50) ratio (or therapeutic index) in these individuals.Tend not to give other cough-and-cold medic

Article Under Review